A purpose-built platform for expanded access management
In this webinar, we’ll reveal how a purpose-built platform can transform the way BioPharma teams manage Expanded Access Programs (EAPs) with greater speed, compliance, and operational control.
Warning: Trying to access array offset on value of type null in /var/www/html/wp-content/themes/custom/acf-flexible/section-part/header_–_left_content_right_image_patient.php on line 18
Warning: Trying to access array offset on value of type null in /var/www/html/wp-content/themes/custom/acf-flexible/section-part/header_–_left_content_right_image_patient.php on line 22
Why attend?
Date: June 26th, 2025 at 5:00 pm CEST / 11:00 am EST
What you will learn:
Understand how rising demand, global variation, and regulatory complexity are reshaping operational expectations for Expanded Access Programs (EAPs).
Explore why traditional tools and ad-hoc processes fall short at scale, and how a platform-first approach can close critical gaps in execution, compliance, and coordination.
Discover how our platform solution, built on 10+ years of operational experience in global EAP delivery, streamlines physician intake, task management, workflow configuration, and case tracking.
See a live demo of the myTomorrows EAP platform and get an early look at upcoming AI-driven features that enhance transparency, automate workflows, and enable data-driven decisions.
Who should join: BioPharma professionals involved in Expanded Access
Previously Kempen & Co Life Sciences. Dennis is responsible for developing strategic partnerships across all stakeholders. With 9+ years of expertise in EA and Clinical Trial Recruitment, and his vast industry network, Dennis plays a key role in the pre-approval access space as an established thought leader, hosting conferences and webinars.
Stephanie Ferket
Director, Expanded Access Strategy and Customer Success at myTomorrows
Previously Alexion, AstraZeneca Rare Disease. Stephanie most recently led the transformation of the access to medicines framework for Alexion, AstraZeneca Rare Disease, and managed EA strategy development and operational execution across all therapeutic areas.
Bryan Berger
Senior Product Manager at myTomorrows
Bryan is currently a Product Manager at myTomorrows with a background in digital health, having worked with Novartis, Novo Nordisk, Merck Group, GE Healthcare and others. He has led the design of platforms and programs that support treatment access, patient engagement, and new care models – now focused on transforming how Expanded Access is delivered at scale.
